Background illustration for clinical trials search

Paid Clinical Trials Paterson

Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: New York NY, East Brunswick NJ, Baltimore MD, Boston MA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase2, Recruiting

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

for
Peripheral Nerve Injury Upper Limb,
Location: New York NY, Camden NJ, Philadelphia PA, Baltimore MD,
Sponsor: Neuraptive Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT06616025

Phase3, Recruiting

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

for
Hypogonadism
Location: New York NY, Edison NJ, Garden City NY,
Sponsor: Acerus Pharmaceuticals Corporation

Sex: Male

Age: 18 - 70+

Code: NCT04976595

Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: New York NY, East Brunswick NJ, Fairfax VA, Columbus OH,
Sponsor: Tubulis GmbH

Sex: All

Age: 18+

Code: NCT06303505

Phase1, Phase2, Recruiting

Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™

for
Coagulation
Location: Denville NJ, Danbury CT, Cooperstown NY, Rockville MD
Sponsor: Perosphere Technologies Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012291

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

for
Glomerular Disease, Proteinuria
Location: Jersey City NJ, Columbus GA, Saint Louis MO, Edina MN,
Sponsor: Angion Biomedica Corp

Sex: All

Age: 18+

Code: NCT04939116

Phase2, Recruiting

Using the Hunt Motivational Scale to Aid in Weight Loss and Weight Maintenance

for
Weight Loss
Location: Plainsboro NJ
Sponsor: Penn Medicine Princeton Health

Sex: All

Age: 0+

Code: NCT03530553

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: New York NY, The Bronx NY, Mineola NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: New York NY, Livingston NJ, New Haven CT,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Prevail Global Study

for
Coronary Artery Disease
Location: Paramus NJ, New York NY, Roslyn NY, Allentown PA,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Persona Revision Knee System Outcomes

for
Arthroplasty Complications, Infection, Knee Disease,
Location: Chester NJ, Cleveland OH, Rochester MI, Southfield MI,
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT04821154

Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: New York NY, Mineola NY, Stony Brook NY, Camden NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: New York NY, Summit NJ, East Brunswick NJ, York PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase3, Recruiting

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Metastatic Non-small Cell Lung Cancer
Location: New York NY, Morristown NJ, The Bronx NY, Northfield NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06417814

Phase3, Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: New York NY, New Brunswick NJ, Boston MA, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase1, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: New York NY, Mineola NY, East Brunswick NJ, Boston MA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase1, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: New York NY, Summit NJ, White Plains NY,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: New Brunswick NJ, Toronto, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase1, Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: New York NY, Lake Success NY, East Brunswick NJ,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase3, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: New York NY, Florham Park NJ, Brooklyn NY, Mineola NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase3, Recruiting